Organon Usa Inc Drug Patent Portfolio
Organon Usa Inc owns 3 orange book drugs protected by 5 US patents Given below is the complete list of Organon Usa Inc's drugs and the patents protecting them.
1. Follistim
Follistim is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5767251 | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
16 Jun, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Follistim's drug page
2. Follistim Aq
Follistim Aq is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7446090 | FSH formulation |
23 Aug, 2019
(5 years ago)
| Expired |
| US7563763 | FSH and FSH variant formulations, products and methods |
23 Aug, 2019
(5 years ago)
| Expired |
| US5929028 | Liquid gonadotropin containing formulations |
14 Jan, 2018
(6 years ago)
| Expired |
| US5767251 | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
16 Jun, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Follistim Aq's drug page
3. Raplon
Raplon is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5418226 | Monoquaternary 2,16-bispiperidinylandrostane derivatives |
14 Apr, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Raplon's drug page